Combinatorial nanococktails via self-assembling lipid prodrugs for synergistically overcoming drug resistance and effective cancer therapy
Open Access
- 31 January 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 26 (1) , 1-18
Abstract
Background: Combinatorial systemic chemotherapy is a powerful treatment paradigm against cancer, but it is fraught with problems due to the emergence of chemoresistance and additive systemic toxicity. In addition, coadministration of individual drugs suffers from uncontrollable pharmacokinetics and biodistribution, resulting in suboptimal combination synergy. Methods: Toward the goal of addressing these unmet medical issues, we describe a unique strategy to integrate multiple structurally disparate drugs into a self-assembling nanococktail platform. Conjugation of a polyunsaturated fatty acid (e.g., linoleic acid) with two chemotherapies generated prodrug entities that were miscible with tunable drug ratios for aqueous self-assembly. In vitro and in vivo assays were performed to investigate the mechanism of combinatorial nanococktails in mitigating chemoresistance and the efficacy of nanotherapy. Results: The coassembled nanoparticle cocktails were feasibly fabricated and further refined with an amphiphilic matrix to form a systemically injectable and PEGylated nanomedicine with minimal excipients. The drug ratio incorporated into the nanococktails was optimized and carefully examined in lung cancer cells to maximize therapeutic synergy. Mechanistically, subjugated resistance by nanococktail therapy was achieved through the altered cellular uptake pathway and compromised DNA repair via the ATM/Chk2/p53 cascade. In mice harboring cisplatin-resistant lung tumor xenografts, administration of the nanococktail outperformed free drug combinations in terms of antitumor efficacy and drug tolerability. Conclusion: Overall, our study provides a facile and cost-effective approach for the generation of cytotoxic nanoparticles to synergistically treat chemoresistant cancers.Keywords
Funding Information
- Zhejiang Provincial Natural Science Foundation of China (LR19H160002)
- National Natural Science Foundation of China (82073296, 81773193, 81571799)
This publication has 64 references indexed in Scilit:
- ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damageCell Cycle, 2013
- RAD51 paralogs: Roles in DNA damage signalling, recombinational repair and tumorigenesisSeminars in Cell & Developmental Biology, 2011
- Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer CellsACS Nano, 2011
- Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in GliomasCancer Cell, 2010
- Mechanism of p53 stabilization by ATM after DNA damageCell Cycle, 2010
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- The roles of copper transporters in cisplatin resistanceCancer and Metastasis Reviews, 2007
- p53 in recombination and repairCell Death & Differentiation, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Irinotecan and Platinums in the Treatment of Non–Small-Cell Lung CancerClinical Lung Cancer, 2001